ARE Th2 HELPER T LYMPHOCYTES BENEFICIAL, DELETERIOUS, OR IRRELEVANT IN PROMOTING ALLOGRAFT SURVIVAL?1
- 1 March 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (5), 619-624
- https://doi.org/10.1097/00007890-199703150-00001
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- INTRAGRAFT IL-15 TRANSCRIPTS ARE INCREASED IN HUMAN RENAL ALLOGRAFT REJECTION1Transplantation, 1996
- CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.The Journal of Experimental Medicine, 1995
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.The Journal of Experimental Medicine, 1994
- Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.The Journal of Experimental Medicine, 1993
- Interleukin-10Annual Review of Immunology, 1993
- CELLS MEDIATING ALLOGRAFT REJECTIONTransplantation, 1991
- Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway.The Journal of Experimental Medicine, 1991
- Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines.Proceedings of the National Academy of Sciences, 1990
- Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.Proceedings of the National Academy of Sciences, 1986